.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
US Department of Justice
Cantor Fitzgerald
Queensland Health
Argus Health
McKesson
Teva
QuintilesIMS
Chubb
Express Scripts

Generated: December 16, 2017

DrugPatentWatch Database Preview

KLOR-CON Drug Profile

« Back to Dashboard

When do Klor-con patents expire, and what generic alternatives are available?

Klor-con is a drug marketed by Upsher-smith Labs and is included in four NDAs.

The generic ingredient in KLOR-CON is potassium chloride. There are two hundred and thirty-two drug master file entries for this compound. Seventy-five suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Upsher-smith LabsKLOR-CONpotassium chlorideCAPSULE, EXTENDED RELEASE;ORAL203106-001Jul 10, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Upsher-smith LabsKLOR-CON M15potassium chlorideTABLET, EXTENDED RELEASE;ORAL074726-003Jun 6, 2003RXNoNo► Subscribe► Subscribe► Subscribe
Upsher-smith LabsKLOR-CONpotassium chlorideTABLET, EXTENDED RELEASE;ORAL019123-001Apr 17, 1986AB2RXYesNo► Subscribe► Subscribe► Subscribe
Upsher-smith LabsKLOR-CON M20potassium chlorideTABLET, EXTENDED RELEASE;ORAL074726-001Nov 20, 1998AB1RXNoYes► Subscribe► Subscribe► Subscribe
Upsher-smith LabsKLOR-CONpotassium chlorideCAPSULE, EXTENDED RELEASE;ORAL203106-002Jul 10, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Upsher-smith LabsKLOR-CONpotassium chlorideFOR SOLUTION;ORAL209662-001Oct 23, 2017AARXNoNo► Subscribe► Subscribe► Subscribe
Upsher-smith LabsKLOR-CON M10potassium chlorideTABLET, EXTENDED RELEASE;ORAL074726-002Aug 9, 2000AB1RXNoNo► Subscribe► Subscribe► Subscribe
Upsher-smith LabsKLOR-CONpotassium chlorideTABLET, EXTENDED RELEASE;ORAL019123-002Apr 17, 1986AB2RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Johnson and Johnson
Federal Trade Commission
Chubb
US Army
Baxter
Express Scripts
Accenture
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot